title: BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.
authors: Chelsea and Westminster NHS Healthcare Trust, London, UK. anton.pozniak@chelwest.nhs.uk
authors: A L
authors: AL
authors: Pozniak
authors: R F
authors: RF
authors: Miller
authors: M C I
authors: MC
authors: Lipman
authors: A R
authors: AR
authors: Freedman
authors: L P
authors: LP
authors: Ormerod
authors: M A
authors: MA
authors: Johnson
authors: S
authors: S
authors: Collins
authors: S B
authors: SB
authors: Lucas
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001942:Breast Feeding; D023801:Directly Observed Therapy; D004347:Drug Interactions; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D055502:Secondary Prevention; D017211:Treatment Failure; D014374:Tuberculin Test; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents